Nishani completed her PhD in Pharmaceutical Sciences at the University of Toronto where she explored developmental pathways in Brain Cancer. Currently, she works as a Director of Clinical Operations at Edesa Biotech, an early-stage pharmaceutical company. At Edesa, she manages their pre-clinical and clinical programs to treat inflammatory and immune-related diseases.